Severity Assessment: Can You Pin the Stage on the Patient?
Jennifer Geremia, PA-C
Brooke Hodnick, PA-C, MPAS
IBD Immunopathogenesis: Do You Know What You're Blocking?
Kimberly D. Orleck, PA-C
Case Review: Targets Are Met—Can You Stick the Landing?
David Rubin, MD
Switching Strategies: Switch or Stay—What’s Your Call?
Remission: Can You Prove It?
Tailoring Treatment: Can You Select the Best Therapy?
When Topicals Fail: The New IPC Consensus Every Clinician Should Know
Linda Stein Gold, MD
Bruce Strober, MD, PhD
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
A.J. Gelderblom, MD, PhD
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
Chelsea Cole, MD
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
Michiel van de Sande, MD, PhD
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
Taking Action Against RSV: No Child Unprotected
Tina Q. Tan, MD
Yvonne Maldonado, MD
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
Kathleen Moore, MD, MS
Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
Joyce F. Liu, MD, MPH
Innovations in Precision Medicine: Leveraging Guideline-Based Immunotherapy and Targeted Treatments in Gynecologic Oncology
Brian Slomovitz, MD
Casey Cosgrove, MD
Michelle Flint, WHNP-BS
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.